1-2 of 2
Donia M. Moujalled
Close
Sort by
Journal Articles

Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models

Emma Morrish, Anthony Copeland, Donia M. Moujalled, Jason A. Powell, Natasha Silke, Ann Lin, Kate E. Jarman, Jarrod J. Sandow, Gregor Ebert, Liana Mackiewicz, Jessica A. Beach, Elizabeth L. Christie, Alexander C. Lewis, Giovanna Pomilio, Karla C. Fischer, Laura MacPherson, David D. L. Bowtell, Andrew I. Webb, Marc Pellegrini, Mark A. Dawson, Stuart M. Pitson, Andrew H. Wei, John Silke, Gabriela Brumatti
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5062–5077.
https://doi.org/10.1182/bloodadvances.2020001576
Published: 2020
Includes: Supplemental data
Journal Articles

Cotargeting BCL-2 and MCL-1 in high-risk B-ALL

Donia M. Moujalled, Diane T. Hanna, Soroor Hediyeh-zadeh, Giovanna Pomilio, Lauren Brown, Veronique Litalien, Ray Bartolo, Shaun Fleming, Maïa Chanrion, Sébastien Banquet, Ana-Leticia Maragno, Laurence Kraus-Berthier, Marie Schoumacher, Charles G. Mullighan, Angela Georgiou, Christine A. White, Guillaume Lessene, David C. S. Huang, Andrew W. Roberts, Olivier Geneste, Lorna Rasmussen, Melissa J. Davis, Paul G. Ekert, Andrew Wei, Ashley P. Ng, Seong L. Khaw
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2762–2767.
https://doi.org/10.1182/bloodadvances.2019001416
Published: 2020
Includes: Supplemental data